☆ 4.4 Article

Treatment patterns, survival, and healthcare utilisation and costs in patients with locally advanced and metastatic bladder cancer in Denmark 2015-2020

ACTA ONCOLOGICA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.

Javier Puente et al.

JOURNAL OF CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States

Daniel M. Geynisman et al.

Summary: This large-scale US-based study examined treatment patterns and clinical outcomes in patients with advanced or metastatic urothelial carcinoma. The results highlight the significant unmet need in this population, particularly among cisplatin-ineligible patients.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital

Signe Sorup et al.

Summary: The purpose of this study was to develop algorithms to determine the number of lines of anti-neoplastic therapy per patient based on the Danish National Patient Registry (DNPR) and evaluate which algorithm had the highest percentage agreement with a reference standard of documentation in medical records. The researchers compared two algorithms based on dates and treatment codes in the DNPR, and found that incorporating both specific drug names and a time interval of less than 45 days between consecutive administrations improved the accuracy of the algorithm.

CLINICAL EPIDEMIOLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era

Yuki Kita et al.

Summary: This study analyzed the treatment of patients with advanced urothelial carcinoma after disease progression with pembrolizumab in the real world. The results showed a lack of standard treatment, with only a minority of patients receiving chemotherapy as subsequent systemic treatment. The introduction of enfortumab vedotin is expected to improve treatment outcomes in this setting.

INTERNATIONAL JOURNAL OF UROLOGY (2022)

添加到收藏夹

Article Oncology

Reasons for lack of treatment in patients with locally advanced, unresectable or metastatic urothelial carcinoma

Lise H. Omland et al.

Summary: This study investigated the proportion of patients with locally advanced, unresectable or metastatic urothelial carcinoma who did not receive systemic anticancer treatment, as well as the reasons for lack of treatment and overall survival. The results showed that one in three patients in the pre-immunotherapy era did not receive treatment, primarily due to poor physical condition, decreased renal function, or patient preferences. The findings emphasize the urgent need for novel and better tolerated treatment regimens for this frail patient group.

ACTA ONCOLOGICA (2022)

添加到收藏夹

Meeting Abstract Oncology

Undertreatment rates, associated factors, and survival among patients with locally advanced or metastatic urothelial cancer (la/mUC): A systematic literature review

T. Wilke et al.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada

Nimira Alimohamed et al.

Summary: Real-world data on treatment patterns and survival outcomes of patients with unresectable locally advanced or metastatic urothelial carcinoma (la/mUC) in Canada are limited. This study found that the majority of patients did not receive systemic therapy, and those who did had poor survival outcomes. The results highlight the significant unmet need for safe and efficacious therapies for la/mUC patients in Canada.

CURRENT ONCOLOGY (2022)

添加到收藏夹

Letter Urology & Nephrology

Re: Petros Grivas, Se Hoon Park, Eric Voog, et al. Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial. Eur Urol 2023;84:95-108

Yao-Ning Feng et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Review Public, Environmental & Occupational Health

The Danish health care system and epidemiological research: from health care contacts to database records

Morten Schmidt et al.

CLINICAL EPIDEMIOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Thomas Powles et al.

LANCET (2018)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Data Resource Profile: The Danish National Prescription Registry

Anton Pottegard et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

J. Bellmunt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Medicine, General & Internal

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Jonathan E. Rosenberg et al.

LANCET (2016)

添加到收藏夹

Review Public, Environmental & Occupational Health

The Danish Bladder Cancer Database

Erik Hansen et al.

CLINICAL EPIDEMIOLOGY (2016)

添加到收藏夹

Review Public, Environmental & Occupational Health

The Danish National Patient Registry: a review of content, data quality, and research potential

Morten Schmidt et al.

CLINICAL EPIDEMIOLOGY (2015)

添加到收藏夹

Review Public, Environmental & Occupational Health

The Danish Civil Registration System as a tool in epidemiology

Morten Schmidt et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)

添加到收藏夹

Article Public, Environmental & Occupational Health

The Danish Pathology Register

Beth Bjerregaard et al.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)

添加到收藏夹

Article Oncology

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

CN Sternberg et al.

EUROPEAN JOURNAL OF CANCER (2006)

添加到收藏夹

Article Oncology

Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study

H von der Maase et al.

JOURNAL OF CLINICAL ONCOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.